EnteroBiotix
ID: 7644852EnteroBiotix is a fecal microbiota transplantation founded in 2017 by James McIlroy.
7
Funding Rounds
$90.2m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ja*** Mc***** |
|
- |
Funding
Funding series
Funding Series Analysis
The company EnteroBiotix has raised a total of $90.22m in funding over 7 rounds.
Key Insights:
- EnteroBiotix April 2024 Series B Funding Round: $29m
- EnteroBiotix LTD Funding Round, September 2022: $12.99m
- EnteroBiotix Series A round, September 7, 2022: $21.5m
- EnteroBiotix September 2021 Series A Funding Round: $21m
- EnteroBiotix Seed round, May 2019: $2.6m
- EnteroBiotix May 2019 Seed Funding Round: $2.5m
- EnteroBiotix June 2017 Seed Funding Round: $630k
Industries
EnteroBiotix is active in the following industries: